| |
| Please Note - Streaming News is only available to subscribers to the Active Level and above |
|
|
|
Renalytix welcomes new US coverage pathway for diagnostic tests
StockMarketWire.com
|
Kidney disease diagnostics group Renalytix welcomed news that a new coverage pathway had been established in the US for medical devices and diagnostics tests.
The Centers for Medicaid & Medicare had set up the Medicare Coverage of Innovative Technology pathway, for Medicare beneficiaries nationwide.
'Having a clear path to national Medicare coverage for innovative products like KidneyIntelX provides a major catalyst to drive the robust research and clinical development programs necessary to address major unmet medical needs such as kidney disease,' president Tom McLain said.
At 9:47am: (LON:RENX) Renalytix Ai PLC share price was 0p at 436p
Story provided by StockMarketWire.com
|
|
|
|
|
|
